A federal jury in northern Indiana hit Johnson & Johnson with a $35 million verdict in a lawsuit over an “unreasonably dangerous” pelvic mesh implant, a team of lawyers has announced.

After two weeks of trial, the nine-person jury in U.S. District Court for the Northern District of Indiana on Friday rendered its verdict against J&J and its subsidiary, Ethicon, for the manufacture, marketing and recruitment of physicians to install the Prolift mesh device intended for repairing prolapsed pelvic organs.